Tumor necrosis factor-α in pregnancies associated with preeclampsia or small-for-gestational-age newborns

American Journal of Obstetrics and Gynecology

Volumn 170, Issue 5, 1994, Pages 1224-1229

  Schiff, Eyal ^a   Friedman, Steven A ^a   Baumann, Peter ^a   Sibai, Baha M ^a   Romero, Roberto ^a  

^a NONE   (United States)

Author keywords

Preeclampsia; small for gestational age; tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; NEWBORN; NORMAL HUMAN; PLASMA; PREECLAMPSIA; PRIORITY JOURNAL; SMALL FOR DATE INFANT;

CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMAN; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; TUMOR NECROSIS FACTOR;

EID: 0028426925     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(94)70130-X     Document Type: Article

References (24)

1. Tumor necrosis, cachexia, shock and inflammation: a common mediator
2. Activation of coagulation after administration of tumor necrosis factor to normal subjects
3. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level
4. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha
5. Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers
6. Leukotriene and prostaglandin production after infusion of tumor necrosis factor in man
7. Tumor necrosis factor alpha mRNA and protein in human placental and uterine cells at early and late stages of gestation
8. Localization of tumor necrosis factor production in cells at the materno/fetal interface in human pregnancy
9. Pathophysiology of preeclampsia
10. Preeclampsia and cytokine induced oxidative stress
11. Fetal growth and perinatal viability in California
12. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids
13. A nonparametric k-sample test for data defined by intervals
14. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
15. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia
16. Tumor necrosis factor α is involved in mouse growth and lymphoid tissue development
17. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationship with growth in normal subjects and in subjects with intrauterine growth retardation
18. Tumor necrosis factor-α in midtrimester amniotic fluid is associaated with impaired intrauterine fetal growth
19. Through thick and thin: wasting, obesity, and TNFα
20. Differential responses of rat trophoblast cells and embryonic fibroblasts to cytokines that regulate proliferation and class I MHC antigen expression
21. Tumor necrosis factor α/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines
22. The growth factor-like effects of tumor necrosis factor-alpha. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes
23. Toxemia: new concepts in an old disease
24. Increased levels of soluble tumor necrosis factor a receptors in serum from pregnant women and in serum and urine samples from newborns